Printer Friendly

Hepatitis B vaccine linked to MS.

Scientists have found that people who develop multiple sclerosis (MS) are more likely than others to have received a hepatitis B vaccination in recent years. Earlier studies investigating a link between the muscle-weakening disease and the vaccine had produced predominantly negative results.

"We were very surprised" by the new finding, says study coauthor Miguel A. Hernan, an epidemiologist at the Harvard School of Public Health in Boston.

Hernan and his colleagues identified 163 MS patients in Britain who had been diagnosed with MS between 1993 and 2000. The scientists matched these patients with 1,604 people without MS who had used the same physicians' offices and were of similar age, gender, and smoking status.

The MS patients were about three times as likely to have had hepatitis B shots in the 3 years preceding onset of MS symptoms as the others were during that same period, Hernan and his coworkers report in the September Neurology. Among the MS patients, 6.7 percent had had a recent hepatitis B vaccination, compared with 2.4, percent among the control group.

The researchers stress that the new study does not prove that the vaccine causes MS. In fact, they note that more than 93 percent of MS patients identified in the study hadn't received hepatitis B shots at all. Nevertheless, the findings suggest a need for scientists to analyze the vaccine's components closely and to confirm the new results, Hernan says. "The last thing we want to do is destroy the reputation of a vaccine that has proved to be very effective and very safe," he says.

Hepatitis B infects 350 million people worldwide and can lead to liver cancer or cirrhosis; MS affects about 2.5 million people.--N.S.
COPYRIGHT 2004 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Biomedicine; multiple sclerosis
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:Sep 25, 2004
Words:288
Previous Article:Heat-controlled implant delivers insulin on demand.
Next Article:Rembrandt's eye saw no depth.
Topics:


Related Articles
Donald Paty awarded first John Dystel Prize.
No foundation for alarm about hepatitis B vaccine.
Shots in the dark: who should decide which vaccinations children receive?
Where are we headed? Experts to review state of MS knowledge.
Interested in clinical trials? NARCOMS may help.
Interferon delays multiple sclerosis.
Confirmed: no link between hepatitis B vaccinations and MS. (News).
Hepatitis B in women: domestically and internationally.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters